Which medications in the drug class Corticosteroid Ophthalmic Implants are used in the treatment of Iritis and Uveitis?

Updated: Jan 15, 2019
  • Author: Monalisa N Muchatuta , MD, MS; Chief Editor: Gil Z Shlamovitz, MD, FACEP  more...
  • Print
Answer

Corticosteroid Ophthalmic Implants

Corticosteroid ophthalmic implants preclude risk associated with systemic steroids and provide continuous therapy for 30-36 months.

Fluocinolone intravitreal implant (Retisert, Yutiq)

The implants are surgically inserted by the ophthalmologist and indicated for chronic, noninfectious uveitis of posterior segment of eye. Retisert releases 0.6 mcg/day initially; amount released decreases after the first month to 0.3-0.4 mcg/day over ~30 months. Yutiq releases at a rate of 0.25 mcg/day over ~36 months.

Dexamethasone intravitreal implant (Ozurdex)

The implant is surgically inserted by the ophthalmologist and indicated for chronic, noninfectious uveitis of posterior segment of eye.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!